Home GLP-1 medicines
Put the GLP-1 chatter beside the actual evidence
Semaglutide and tirzepatide often get mentioned in the same breath. They’re different medicines, and each has FDA-approved products for type 2 diabetes and for weight management in particular groups. The product matters: an approval for one use doesn’t cover every reason someone might want it.
The appetite part has a real explanation
GLP-1 is a gut hormone that helps regulate appetite and blood sugar. Semaglutide copies that signal. Tirzepatide also activates the receiving points for a second gut hormone, called GIP, as the Zepbound (tirzepatide) label explains. Two targets don’t tell us which medicine fits your health.
That appetite effect is part of how these medicines work. I don’t read someone’s changed appetite as a sudden improvement in willpower. I’d rather talk about what they need from care and what the trade-offs might be. The common side effects are mostly digestive: constipation, nausea, diarrhea and vomiting.
The trials mean something, within their boundaries
A semaglutide trial in adults without diabetes found more weight loss than placebo, a comparison treatment without the active medicine. Participants had obesity, or overweight with a related health problem. Both groups received lifestyle support, so that support belongs in the story too.
A tirzepatide trial in adults without diabetes also found greater weight loss than placebo. These are useful findings about the people studied. They can’t tell a friend what result to expect or decide which product is suitable for them.
The cautions are part of the story
The Wegovy (semaglutide) label has a boxed warning about tumors in the thyroid’s C cells seen in rodents. Whether these medicines cause those tumors in people is unknown. The label rules it out with a personal or family history of medullary thyroid cancer, a rare thyroid cancer, or multiple endocrine neoplasia syndrome type 2, an inherited condition that can cause tumors. Zepbound has the same exclusions.
A familiar ingredient name doesn’t make a compounded preparation an approved product. Compounded medicines are not FDA-approved. A licensed U.S. clinician can assess your health and discuss an approved option where appropriate. The care questions help get that conversation ready without picking a treatment for you.